← FDA Drug Approvals (Drugs@FDA)

NEUTREXIN

NDA · New Drug Application · Sponsor: MEDIMMUNE ONCOLOGY · Approved 1993-12-17

Drug application

FDA Application #

NDA020326

Application type

New Drug Application

Brand name

NEUTREXIN

Generic name

Trimetrexate Glucuronate

Active ingredients

TRIMETREXATE GLUCURONATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

MEDIMMUNE ONCOLOGY

First approval

1993-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown